Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results

Published 22/05/2024, 19:32
© Reuters.  Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results
TJX
-
IXIC
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 100 points on Wednesday.

The Dow traded down 0.71% to 39,588.89 while the NASDAQ fell 0.66% to 16,721.24. The S&P 500 also fell, dropping, 0.62% to 5,288.55.

Check This Out: Top 5 Industrials Stocks That May Explode This Quarter

Leading and Lagging Sectors

Health care shares rose by 0.2% on Wednesday.

In trading on Wednesday, energy shares fell by 2%.

Top Headline

The TJX Companies, Inc. (NYSE:TJX) reported better-than-expected first-quarter financial results on Wednesday.

The company reported first-quarter FY25 sales growth of 5.9% year-on-year to $12.479 billion, beating the analyst consensus estimate of $12.463 billion. Overall comp store sales increased 3%. EPS of 93 cents beat the consensus estimate of 87 cents.

The company expects FY25 EPS of $4.03-$4.09 (up from $3.94-$4.02)

Equities Trading UP

  • Akoustis Technologies, Inc. (NASDAQ:AKTS) shares shot up 127% to $0.3120 after the company reportedly floated the probability of bankruptcy after losing a lawsuit against Qorvo.
  • Shares of Barnes & Noble Education, Inc. (NYSE:BNED) got a boost, surging 96% to $1.0590 on continued volatility. Greenhaven last week said it continues to explore a possible transaction with the company.
  • Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) shares were also up, gaining 23% to $3.0150 following better-than-expected quarterly financial results.
Equities Trading DOWN

  • Edible Garden AG Incorporated (NASDAQ:EDBL) shares dropped 49% to $2.23 after the company announced the pricing of a $6 million public offering.
  • Shares of Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) were down 42% to $1.36 after the company announced $7 million of gross proceeds from warrant exercises.
  • Oragenics, Inc. (NYSE:OGEN) was down, falling 37% to $1.9124. Oragenics named William “Frank” Peacock MD as Chief Clinical Officer.
Also Check This Out: Qualcomm, American Express And 2 Other Stocks Insiders Are Selling

Commodities

In commodity news, oil traded down 1% to $77.85 while gold traded down 1.4% at $2,392.20.

Silver traded down 2% to $31.445 on Wednesday, while copper fell 5.1% to $4.8440.

Euro zone

European shares were lower today. The eurozone's STOXX 600 fell 0.34%, Germany's DAX fell 0.25% and France's CAC 40 dipped 0.61%. Spain's IBEX 35 Index fell 0.05%, while London's FTSE 100 fell 0.55%.

The annual inflation rate in the UK fell to 2.3% in April from 3.2% in March, while producer prices rose 1.1% year-over-year in April.

Passenger car registrations in the European Union jumped 13.7% year-over-year to 914 thousand units in April.

Asia Pacific Markets

Asian markets closed mixed on Wednesday, with Japan's Nikkei falling 0.85%, China's Composite Index gaining 0.02%, Hong Kong's Hang Seng Index falling 0.13% and India's S&P BSE Sensex gaining 0.2%.

Japanese trade deficit rose to JPY 462,50 billion in April compared to a year-ago gap of JPY 429,79 billion. Japan’s core machinery orders climbed 2.9% month-over-month to 913 billion yen in March.

Economics

U.S. mortgage applications rose by 1.9% from the prior week in the period ending May 17, compared to a 0.5% gain in the prior week.

U.S. existing home sales fell 1.9% month-over-month to an annualized rate of 4.14 million units in April versus a revised 4.22 million in the prior month.

U.S. crude oil inventories climbed by 1.825 million barrels in the week ending May 17, compared to a 2.508 million decline in the prior period, the EIA said. However, analysts were expecting a 2.55 million barrel decline.

Now Read This: Jim Cramer: This Industrial Stock Is Doing ‘Very Well’; Here’s His Take On Palantir

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.